Philadelphia Clinical Site 120 — Philadelphia, Pennsylvania

Philadelphia Clinical Site 120 is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 55/100 (POOR). This profile has not yet been claimed by the site owner.

Philadelphia Clinical Site 120 has participated in 2 clinical trials.

Therapeutic areas: Multiple Sclerosis.

Sponsors: EMD Serono, Ono Pharma USA Inc.

Sponsor Feasibility Report

Trust Score: 55/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Philadelphia Clinical Site 120?

Philadelphia Clinical Site 120 has a Crixeo Trust Score of 55/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Philadelphia Clinical Site 120 conducted?

Philadelphia Clinical Site 120 has 2 clinical trials on record. Their work covers Multiple Sclerosis.

Is Philadelphia Clinical Site 120 accredited by Crixeo Health?

Philadelphia Clinical Site 120 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Philadelphia Clinical Site 120?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.